Performs E2E process related scientific writing that includes but not limited to manage workflow in PubConnect, create publication plan, author approvals, pre-submission queries, submission activities etc.
Assist senior staff in developing sections of a wide range of pharmacovigilance documents including but not limited to various Periodic Safety Reports, Signal Assessment Reports, Safety Strategy and Core Benefit-Risk Documents, Risk-Management Plans, Patient Safety Narratives and Health Hazard Reports.
Advanced degree in Life Sciences, Pharmacy, Medicine, or related field, with a minimum of 3-5 years of experience in medical writing within the pharmaceutical, biotechnology, or contract research organization industry.
PhD (Life Sciences) OR PharmD OR M.Pharm/M.Sc with a good understanding of clinical research and medical communication. Preferable to have some experience working on Global Medical Value, GMV Dossiers.
A good life science undergraduate degree from a reputable university is required. Postgraduate qualifications such as MSc/MRes or PhD are preferred. Internal training on value communication, market access, pricing and reimbursement, health economics, modeling, statistics, referencing, proofing etc. provided.
Minimum 2 years of experience in the medical writing industry; freshers with substantial knowledge of the publication landscape or clinical research are also eligible.
Liaise and build trusting and professional relationships with international pharmaceutical clients, healthcare professionals, internal and external stakeholders, including authors, reviewers, and key opinion leaders across therapeutic areas - learning to anticipate their needs.
Bachelors degree in Life Sciences, Pharmacy, Medicine, or related field, with a keen interest in medical writing, clinical research, and drug development processes. Excellent written and verbal communication skills, with the ability to translate complex medical and scientific information into clear, concise, and engaging content tailored to diverse audiences.